0 items USD 0.00Search
Your search for "Hodgkin%20Lymphoma%20" gave back 1646 results.
Market Analysis and Insights: Global Hodgkin Lymphoma Treatment Market The global Hodgkin Lymphoma Treatment market is projected to grow from US$...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
The “Hodgkin Lymphoma Treatment Industry Forecast” looks at past sales and reviews total world Hodgkin Lymphoma Treatment sales in 2022, providing a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Hodgkin's lymphoma is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Hodgkin Lymphoma Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Publisher' newest research report, the “Non-Hodgkin Lymphoma Therapeutics Industry Forecast” looks at past sales and reviews total world Non-...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Adult Non-Hodgkin Lymphoma Treatment market size was valued at USD 7820 million in 2022 and is forecast to a readjusted size of USD 13440...
Catalog:
GIR
August 2023
Price: USD 3,480.00
According to our Publisher latest study, the global Non-Hodgkin Lymphoma Therapeutics market size was valued at USD million in 2022 and is forecast...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Non-Hodgkin Lymphoma - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,500.00
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
August 2018
Price: USD 2,000.00
The “B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry Forecast” looks at past sales and reviews total world B-Cell Non-Hodgkin's...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
February 2018
Price: USD 2,000.00
